Monday Deal Review: September 31, 2012

Welcome to your Monday Biotech Deal Review for September 31, 2012. This week’s big news is yet another acquisition by Valeant, this time for the U.S rights and inventory of an age-related macular degeneration treatment from QLT Inc. Find more details on this story and others by clicking through.
Flag this


There are currently no comments. Add a new comment!

Post a comment

You must be logged in to post comments. Login now

Posted by Mike Gene


Hi my name is Mike Gene and I forgot to add my bio. Next time you see me remind me to update my bio information.

0 people like this

Be the first to like this